AMARIN CORP PLC\UK Share Price
AMARIN CORP PLC\UK (AMRN) had Share Price of $2.39 per share as of 2015-03-31, per its 10-Q filed 2015-05-08.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:SharePrice · last filed 2020-02-25
- 2015-03-31: Share Price $2.39.
- 2015-03-05: Share Price $2.39.
- 2014-12-31: Share Price $0.98.
- 2014-09-30: Share Price $1.09.
| Period end | Share Price |
|---|---|
| 2015-03-31 | $2.39 10-Q · filed 2015-05-08 |
| 2015-03-05 | $2.39 10-K · filed 2020-02-25 |
| 2014-12-31 | $0.98 10-K · filed 2015-03-03 |
| 2014-09-30 | $1.09 10-Q · filed 2014-11-06 |
| 2014-06-30 | $1.76 10-Q · filed 2014-08-07 |
| 2014-03-31 | $1.81 10-Q · filed 2014-05-09 |
| 2013-12-31 | $1.97 10-K · filed 2014-02-27 |
| 2013-09-30 | $6.32 10-Q · filed 2013-11-07 |
| 2013-06-28 | $5.80 10-Q · filed 2013-08-08 |
| 2013-03-28 | $7.41 10-Q · filed 2013-05-09 |
| 2012-12-31 | $8.09 10-K · filed 2013-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B |